Moreover, Savry et al demonstrated that the Bcl-2 overexpression enhances the efficacy of vinorelbine and paclitaxel in lung and breast cancer cells through upregulation of Bim (32). This evidence concerns the gene BCL2L11 and breast carcinoma.